BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2359388)

  • 21. [Intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in unresectable metastatic liver carcinoma].
    Arai K; Mori T; Kitamura M; Yoshikawa T; Takahashi T; Awane Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2596-600. PubMed ID: 3137881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
    Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W
    Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat.
    Teder H; Johansson CJ
    Anticancer Res; 1993; 13(6A):2161-4. PubMed ID: 8297129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental and clinical studies on degradable starch microspheres (DSM) in the treatment of hepatic neoplasms].
    Yamada T; Nakamura K; Matsuo R; Murata K; Usuki N; Kaminou T; Tsubakimoto M; Manabe T; Takashima S; Nakatsuka H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2617-20. PubMed ID: 3137884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver tumor targeting of drugs: Spherex, a vascular occlusive agent].
    Taguchi T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):969-76. PubMed ID: 7794007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment].
    Kitamura M; Arai K; Miyashita K; Kosaki G
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2936-9. PubMed ID: 2506831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental and clinical studies of degradable starch microspheres in the treatment of hepatic neoplasm: Part 1. Experimental study].
    Yamada T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):663-9. PubMed ID: 7478952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy].
    Takeuchi I; Ishida H; Hashimoto D; Mastumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1686-8. PubMed ID: 14619494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phase I study on infusion of PJ-203 (degradable starch microspheres) into hepatic. PJ-203 Clinical Study Group].
    Taguchi T
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1817-25. PubMed ID: 8379675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
    Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
    Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enhancement of anti-tumor effect of adriamycin by verapamil in a intrahepatic arterial infusion in the rats].
    Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Okui K
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):481-7. PubMed ID: 1614393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatic arterial injection of degradable starch microspheres (DSM) combined with adriamycin (ADM) and mitomycin C (MMC) in patients with liver metastasis of colorectal cancer].
    Takeuchi I; Ishida H; Inokuma S; Nakada H; Oosawa T; Sakimoto T; Hashimoto D; Kashimada A; Osada H
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1904-6. PubMed ID: 11086442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors].
    Yoshikawa T; Oyamada H; Itani K; Tainaka K; Seto O; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2646-52. PubMed ID: 2843131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhancement of anti-tumor effects by arterial embolization combined with hyperthermia in the treatment of hepatic tumors].
    Tanaka Y; Murata T; Yoshida M; Kawa S; Sawada S
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):396-403. PubMed ID: 3101604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical trial of degradable starch microspheres (DSM) in the treatment of hepatic malignancies by intra-arterial infusion of anticancer drugs--relationship between quantity of DSM and blockade of arterial blood flow].
    Yamada T; Matsuoka T; Manabe T; Takashima S; Kobayashi N; Tamaoka K; Nakajima T; Nakatsuka H; Nakamura K; Minakuchi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 Nov; 46(11):1259-66. PubMed ID: 3822782
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment with degradable starch microspheres (DSM) in malignant hepatic tumors-clinical experience of implantable drug delivery system (Port-A-Cath)].
    Yamashita K; Hirai K; Aoki Y; Sakai T; Noguchi H; Miyazono K; Abe M; Tanikawa K; Saitu H; Nakayama K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2611-6. PubMed ID: 2843129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Audit of the safety of hepatic arterial infusion of degradable starch microspheres (DSM). Adriamycin (ADM).mitomycin C (MMC) on aged patients with liver metastases of colorectal cancer].
    Takeuchi I; Ishida H; Kuwabara K; Hashimoto D; Osada H; Kashimada A; Matumoto Y; Miura T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2374-6. PubMed ID: 12484078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres.
    Starkhammar H; HÃ¥kansson L; Morales O; Svedberg J
    Acta Oncol; 1987; 26(4):295-300. PubMed ID: 3120760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intra-arterial infusion port system for intermittent degradable starch microsphere chemoembolization and implantation method].
    Takayasu Y; Kotake M; Yokoyama H; Takehara M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3075-80. PubMed ID: 2506835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of portal venous flow on the washout of a regionally injected marker substance 99mTc-methylene diphosphonate after hepatic arterial blockade with degradable starch microspheres.
    Nott DM; Yates J; Grime SJ; Maltby M; Cooke TG; Jenkins SA
    Eur J Surg Oncol; 1992 Aug; 18(4):347-52. PubMed ID: 1521628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.